BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/24/2015 11:11:00 AM | Browse: 12368 | Download: 714
Publication Name World Journal of Gastroenterology
Manuscript ID 22321
Country of Manuscript Source China
Received
2015-08-26 08:56
Peer-Review Started
2015-08-26 09:26
To Make the First Decision
2015-09-29 17:03
Return for Revision
2015-10-05 14:58
Revised
2015-10-17 20:58
Second Decision
2015-11-27 08:32
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-12-08 17:14
Articles in Press
2015-12-08 17:14
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-12-11 14:36
Publish the Manuscript Online
2015-12-24 11:11
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Minireviews
Article Title High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment
Manuscript Source Invited Manuscript
All Author List Mei Zhang
Funding Agency and Grant Number
Corresponding author Mei Zhang, MD, Chief Physician, Professor, Department of Gastroenterology, Xuanwu Hospital, Capital Medical University, No.45 Changchun Street, Xuanwu District, Beijing 100053, China. zhang2955@sina.com
Keywords Helicobacter pylori; Resistance; Eradication treatment; Triple antibiotic therapy; Gastrointestinal disease
Core Tip Helicobacter pylori (H. pylori) infection is associated with a variety of upper gastrointestinal diseases, including gastric cancer. H. pylori eradication treatment failure affects the outcome of these diseases. The eradication rate of triple antibiotic therapy, the worldwide gold standard, is currently less than 80% in most parts of the world. Antibiotic resistance is the main reason for treatment failure, therefore the standard triple regimen is no longer suitable as a first-line treatment for the majority of the world. H. pylori eradication treatment may fail for a number of reasons, including H. pylori strain factors, host factors, environmental factors, and inappropriate treatment.
Publish Date 2015-12-24 11:11
Citation Zhang M. High antibiotic resistance rate: A difficult issue for Helicobacter pylori eradication treatment. World J Gastroenterol 2015; 21(48): 13432-13437
Url http://www.wjgnet.com/1007-9327/full/v21/i48/13432.htm
DOI http://dx.doi.org/10.3748/wjg.v21.i48.13432
Full Article (PDF) WJG-21-13432.pdf
Full Article (Word) WJG-21-13432.doc
Manuscript File 22321-Review.docx
Answering Reviewers 22321-Answering reviewers.pdf
Audio Core Tip 22321-Audio core tip.mp3
Conflict-of-Interest Disclosure Form 22321-Conflict-of-interest statement.pdf
Copyright License Agreement 22321-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate 22321-Language certificate.pdf
Peer-review Report 22321-Peer-review(s).pdf
Scientific Misconduct Check 22321-Scientific misconduct check.pdf
Scientific Editor Work List 22321-Scientific editor work list.pdf